The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...
Practice-changing studies in dry age-related macular degeneration (AMD) and promising new directions in wet AMD, presented at ...
Medpage Today on MSN3d
FDA Grants Market Authorization to Light-Therapy System for Dry AMDThe FDA announced marketing authorization of a form of light therapy as the first-ever treatment for dry age-related macular ...
AMD progressively damages the center of the retina, the light-detecting region at the back of the eye. Recent data suggests ...
The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to ...
The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).
Researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases
Rensselaer researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.
Woman's World on MSN9d
4 Macular Degeneration Self-Care Tips to Protect Your VisionIf your vision is blurry or fuzzy, or if you notice that straight lines appear curved or wavy, you may have age-related ...
The US Food and Drug Administration has FDA has granted marketing authorization to a form of light therapy as the first-ever ...
PulseSight plans to submit a phase I clinical trial authorization (CTA) by the end the year, to be closely followed by a phase II proof-of-concept to demonstrate the efficacy and the safety of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback